Argent Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Argent Financial Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$422K	Buy	+8,163	New	+$383K	0.05%	226

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Argent Financial Group's BMY Position: Q3 2024 in Review

Argent Financial Group opened a new position in Bristol-Myers Squibb (BMY) in Q3 2024: 8,163 shares worth $422K. The stake represents 0.05% of the portfolio and ranks #226 among its holdings.

2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Argent Financial Group held 8,163 shares of Bristol-Myers Squibb worth $422K as of Q3 2024.
Bristol-Myers Squibb was a new Argent Financial Group position in Q3 2024.
Bristol-Myers Squibb made up 0.05% of Argent Financial Group's portfolio in Q3 2024, its #226 holding.
2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Argent Financial Group's 13F filing for Q3 2024, filed 13 Nov 2024.